Growth capital is equity or structured equity funding for scaling businesses that already demonstrate traction—bridging late venture and pre-IPO expansion needs.

How it works

Companies raising growth capital usually have meaningful revenue, repeatable GTM, and a plan to deploy capital into headcount, geographic expansion, product adjacencies, or tuck-in acquisitions. Investors may be venture growth funds, crossover investors, or growth equity firms. Terms often involve minority stakes, though larger checks can approach control thresholds. Use of proceeds is specific—hiring 50 sales reps, entering EMEA—not exploratory R&D. Growth capital sits later than seed or Series A risk; diligence emphasizes retention, payback periods, and path to profitability or IPO.

Why it matters

• Founders: Match capital type to milestones—growth capital investors penalize “science projects” without ROI timelines.
• Investors: Underwrite incremental returns from capital deployment, not just narrative TAM expansion.

Common mistake

Raising growth capital to fix a broken core product. Capital accelerates what works; it rarely invents fit.

Related ideas

Growth equity, growth investor, crossover round, and secondary liquidity for founders.